LASHANDIA MAY: Open Payments
NPI 1992193684 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,195 in 12 payments from 8 companies in 2025. Trend: 2023 $695 · 2024 $115 · 2025 $1,195
Food & beverage: $1,195
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $287 |
| ABBVIE INC. | 2 | $243 |
| Axsome Therapeutics, Inc. | 2 | $138 |
| Teva Pharmaceuticals USA, Inc. | 2 | $135 |
| Alkermes, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
| Lilly USA, LLC | 1 | $25 |
Products named: INVEGA SUSTENNA, SPRAVATO, Auvelity, UZEDY, VRAYLAR, LYBALVI, INGREZZA, COBENFY.
Industry payments across FL — which companies pay providers there.
